Study of Ibrutinib in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed/Relapsed and Refractory Multiple Myeloma
Clinical trial NCT02902965 · COMPLETED
Trial details
- NCT number
- NCT02902965
- Sponsor
- Pharmacyclics Switzerland GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-20
- Primary completion
- 2018-10-26
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.